Enanta Pharmaceuticals Inc
ENTANasdaqCIK 1177648HealthcareFiscal year ends Sep 30
Reports and events: 195 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:05 ET | 8-K | 8.01 Other events | 0001193125-26-437774 |
| 2026-10-2807:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-435092 |
| 2026-08-1207:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-345719 |
| 2026-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342336 |
| 2026-07-0216:56 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-294837 |
| 2026-06-2317:28 ET | 8-K | 8.01 Other events | 0001193125-26-279803 |
| 2026-06-1807:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-274950 |
| 2026-05-1307:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-220572 |
| 2026-05-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216735 |
| 2026-03-2608:00 ET | 8-K | 8.01 Other events | 0001193125-26-125113 |
| 2026-03-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-104109 |
| 2026-02-1116:00 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001193125-26-046502 |
| 2026-02-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-042812 |
| 2026-01-2616:05 ET | DEF 14A | Proxy statementPeriod 2026-03-11 | 0001193125-26-022558 |
| 2025-11-1916:16 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001193125-25-288121 |
| 2025-11-1716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-284633 |
| 2025-10-0116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-226828 |
| 2025-09-2908:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-221791 |
| 2025-09-2906:51 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-221527 |
| 2025-08-2716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-189691 |
| 2025-08-2007:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-183719 |
| 2025-08-1316:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-179795 |
| 2025-08-1116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-177941 |
| 2025-05-1416:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071340 |
| 2025-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069155 |
| 2025-03-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-040230 |
| 2025-02-1417:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-021421 |
| 2025-02-1216:00 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000950170-25-018810 |
| 2025-02-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-017035 |
| 2025-01-2716:00 ET | DEF 14A | Proxy statementPeriod 2025-03-13 | 0000950170-25-009168 |
| 2024-12-0908:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-272936 |
| 2024-11-2708:35 ET | 10-K | Annual reportPeriod 2024-09-30 | 0000950170-24-131260 |
| 2024-11-2516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-130553 |
| 2024-08-0716:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092714 |
| 2024-08-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-090722 |
| 2024-05-0816:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055581 |
| 2024-05-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053532 |
| 2024-03-1216:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-029889 |
| 2024-02-0816:24 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0000950170-24-012796 |
| 2024-02-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-012186 |
| 2024-01-2616:25 ET | DEF 14A | Proxy statementPeriod 2024-03-06 | 0000950170-24-007956 |
| 2023-12-2616:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-303014 |
| 2023-11-2216:21 ET | 10-K | Annual reportPeriod 2023-09-30 | 0000950170-23-065884 |
| 2023-11-2016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-065087 |
| 2023-08-0816:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039754 |
| 2023-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039051 |
| 2023-06-0707:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-026739 |
| 2023-05-0917:07 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019842 |
| 2023-05-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-018788 |
| 2023-04-2716:43 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-122434 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.